Craft

Chase Therapeutics

Total Funding

$5.3 M

Chase Therapeutics Summary

Company Summary

Overview
Chase Therapeutics is a pharmaceutical company focused on the development of treatments for brain diseases. It provides products for those affected by central nervous system disorders such as Parkinson’s disease, major depressive disorder, and Parkinson-related dementia.
Type
Private
Status
Active
Founded
2017
HQ
Washington, DC, US | view all locations
Website
http://www.chasetherapeutics.com/
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

1 location detected

  • Washington, DC HQ

    United States

    1825 K St NW #510

Footer menu